ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/07 | 1,886 | 1,947 | 1,885 | 1,932 | +34 | +1.8% | 721,000 |
| 2022/12/06 | 1,871 | 1,929 | 1,867 | 1,898 | +21 | +1.1% | 632,300 |
| 2022/12/05 | 1,841 | 1,888 | 1,836 | 1,877 | +23 | +1.2% | 399,900 |
| 2022/12/02 | 1,888 | 1,888 | 1,844 | 1,854 | -27 | -1.4% | 605,800 |
| 2022/12/01 | 1,936 | 1,948 | 1,870 | 1,881 | -15 | -0.8% | 733,000 |
| 2022/11/30 | 1,944 | 1,957 | 1,890 | 1,896 | -68 | -3.5% | 812,400 |
| 2022/11/29 | 1,904 | 1,976 | 1,886 | 1,964 | +48 | +2.5% | 1,103,000 |
| 2022/11/28 | 1,904 | 1,980 | 1,899 | 1,916 | +83 | +4.5% | 1,636,000 |
| 2022/11/25 | 1,874 | 1,880 | 1,808 | 1,833 | -51 | -2.7% | 1,210,800 |
| 2022/11/24 | 1,918 | 1,935 | 1,879 | 1,884 | -23 | -1.2% | 986,500 |
| 2022/11/22 | 1,918 | 1,937 | 1,890 | 1,907 | -16 | -0.8% | 824,500 |
| 2022/11/21 | 1,980 | 1,980 | 1,923 | 1,923 | -37 | -1.9% | 632,500 |
| 2022/11/18 | 1,975 | 1,982 | 1,947 | 1,960 | -20 | -1% | 734,000 |
| 2022/11/17 | 2,000 | 2,014 | 1,975 | 1,980 | -44 | -2.2% | 774,000 |
| 2022/11/16 | 2,049 | 2,070 | 1,995 | 2,024 | -23 | -1.1% | 1,107,300 |
| 2022/11/15 | 1,950 | 2,060 | 1,946 | 2,047 | +126 | +6.6% | 1,773,000 |
| 2022/11/14 | 1,940 | 2,009 | 1,915 | 1,921 | -17 | -0.9% | 1,554,300 |
| 2022/11/11 | 1,950 | 1,961 | 1,907 | 1,938 | +12 | +0.6% | 832,800 |
| 2022/11/10 | 1,895 | 1,934 | 1,890 | 1,926 | +17 | +0.9% | 530,200 |
| 2022/11/09 | 1,982 | 1,985 | 1,901 | 1,909 | -64 | -3.2% | 1,198,800 |
| 2022/11/08 | 1,997 | 2,021 | 1,971 | 1,973 | -9 | -0.5% | 552,200 |
| 2022/11/07 | 1,984 | 1,994 | 1,954 | 1,982 | -22 | -1.1% | 556,300 |
| 2022/11/04 | 2,000 | 2,012 | 1,982 | 2,004 | -7 | -0.3% | 480,300 |
| 2022/11/02 | 2,017 | 2,030 | 1,972 | 2,011 | -19 | -0.9% | 909,800 |
| 2022/11/01 | 2,037 | 2,052 | 2,003 | 2,030 | -3 | -0.1% | 592,900 |
| 2022/10/31 | 2,078 | 2,088 | 2,023 | 2,033 | -31 | -1.5% | 983,900 |
| 2022/10/28 | 2,050 | 2,081 | 2,031 | 2,064 | -21 | -1% | 865,000 |
| 2022/10/27 | 2,073 | 2,116 | 2,068 | 2,085 | -9 | -0.4% | 1,076,000 |
| 2022/10/26 | 1,992 | 2,100 | 1,992 | 2,094 | +114 | +5.8% | 2,071,700 |
| 2022/10/25 | 1,948 | 1,982 | 1,944 | 1,980 | +39 | +2% | 560,300 |
| 2022/10/24 | 1,946 | 1,967 | 1,932 | 1,941 | ±0 | ±0% | 596,600 |
| 2022/10/21 | 1,961 | 1,972 | 1,924 | 1,941 | -31 | -1.6% | 763,600 |
| 2022/10/20 | 2,003 | 2,008 | 1,939 | 1,972 | -46 | -2.3% | 1,432,600 |
| 2022/10/19 | 2,036 | 2,055 | 2,008 | 2,018 | -12 | -0.6% | 825,300 |
| 2022/10/18 | 2,027 | 2,034 | 1,994 | 2,030 | +14 | +0.7% | 1,094,100 |
| 2022/10/17 | 2,030 | 2,084 | 2,016 | 2,016 | +41 | +2.1% | 2,203,200 |
| 2022/10/14 | 1,900 | 1,984 | 1,897 | 1,975 | +105 | +5.6% | 1,598,800 |
| 2022/10/13 | 1,897 | 1,904 | 1,862 | 1,870 | -27 | -1.4% | 600,800 |
| 2022/10/12 | 1,913 | 1,927 | 1,881 | 1,897 | -13 | -0.7% | 712,500 |
| 2022/10/11 | 1,895 | 1,928 | 1,890 | 1,910 | +6 | +0.3% | 583,800 |
| 2022/10/07 | 1,948 | 1,966 | 1,896 | 1,904 | -42 | -2.2% | 920,600 |
| 2022/10/06 | 1,911 | 1,963 | 1,908 | 1,946 | +31 | +1.6% | 1,105,600 |
| 2022/10/05 | 1,903 | 1,927 | 1,883 | 1,915 | -8 | -0.4% | 791,900 |
| 2022/10/04 | 1,912 | 1,925 | 1,880 | 1,923 | +25 | +1.3% | 873,400 |
| 2022/10/03 | 1,840 | 1,900 | 1,811 | 1,898 | +65 | +3.5% | 965,000 |
| 2022/09/30 | 1,865 | 1,873 | 1,815 | 1,833 | -13 | -0.7% | 732,400 |
| 2022/09/29 | 1,830 | 1,886 | 1,816 | 1,846 | +56 | +3.1% | 1,037,600 |
| 2022/09/28 | 1,795 | 1,863 | 1,782 | 1,790 | +6 | +0.3% | 1,360,700 |
| 2022/09/27 | 1,772 | 1,798 | 1,748 | 1,784 | +22 | +1.2% | 786,100 |
| 2022/09/26 | 1,777 | 1,818 | 1,762 | 1,762 | -47 | -2.6% | 1,564,800 |
451～
500
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
